Scientist-founders, commercially trained.
L3 Labs is a brain-longevity biotech spun out of the University of Sydney, building non-invasive medicines that rejuvenate the aging brain and extend cognitive healthspan.
The founding team.
Prof. Greg Neely
Functional genomics and neuroscience, Charles Perkins Centre, University of Sydney.
Dr. Adam Cole
Translational development and platform strategy.
Dr. Julius Juarez
Biotech commercialisation and corporate strategy.
Dr. Maria Bergamasco
Behavioural neuroscience and cognition; co-inventor of L04 and L05.
The founding team completed the CSIRO ON Accelerate commercialisation program (2025) and is participating in the Cicada Innovations STRIDE program (2026), with mentorship focused on biotech commercial and strategic development.
Keep the mind as long as the body.
Advances in longevity are extending the lifespan of the body faster than the brain can keep up. We build medicines to close that gap, so memory, learning and resilience last as long as the years we add.
Restore, don't just slow
We rebuild the synaptic and regenerative machinery that aging strips away, a neurorestorative mechanism, not a brake.
Born from longevity research
The premise comes from our founders' own lab: research showing that targeting the brain can extend lifespan. The lead program applies that principle through a new target and a non-invasive route.
Build the future of brain longevity with us.
We're partnering with investors and institutions who want to extend not just lifespan, but the years we stay fully ourselves.
Start a conversation